Regeneron Pharmaceuticals | REGN - Capitale Ordinario





Capitale Ordinario Cambiamento Data
AbbVie USD 1.77B 608K 2026-06
Agenus USD 38.52M 3.2M 2026-03
Agios Pharmaceuticals USD 59.6M 264K 2026-06
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
Amgen USD 541M 0 2026-09
Astellas Pharma JPY 1.79B 109K 2026-09
AstraZeneca USD 1.55B 28K 2026-09
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.68M 141K 2026-09
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Eli Lilly USD 943.5M 3.33M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
Incyte USD 200.98M 1.03M 2026-06
Ionis Pharmaceuticals USD 166.41M 773K 2026-09
J&J USD 2.41B 1.64M 2026-06
Kyowa Hakko Kirin JPY 523.58M 1000 2026-09
Merck USD 2.47B 1.05M 2026-06
Moderna USD 391M 2M 2025-09
Neurocrine Biosciences USD 101.3M 750K 2026-09
Novartis USD 1.89B 12.09M 2026-09
Novartis USD 1.89B 19.47M 2026-09
Pfizer USD 5.7B 1000K 2026-09
Puma Biotechnology USD 5K 0 2024-06
Regeneron Pharmaceuticals USD 105M 300K 2026-03
Roche Holding CHF 796.77M 1.15M 2026-06
Sanofi EUR 1.2B 2.15M 2026-06
Sarepta Therapeutics USD 107.23M 1.61M 2026-09
Teva Pharmaceutical Industries USD 1.17B 2M 2026-09
Ultragenyx Pharmaceutical USD 98.6M 300K 2026-06
United Therapeutics USD 42.38M 295K 2026-09
Vertex Pharmaceuticals USD 253.5M 200K 2026-09